Press release
Impact of COVID-19 on RNA Interference (RNAi) Drug Delivery Market Which Like to Develop Revenue Growth Strategies
RNA Interference (RNAi) Drug Delivery Market
According to a new report published by Allied Market Research, titled, “RNA Interference (RNAi) Drug Delivery Market by Type of Drug Delivery Technology (Nanoparticle Drug Delivery Technology, Pulmonary Drug Delivery Technology, Nucleic Acid Drug Delivery Technology, and Aptamer Drug Delivery Technology), and Application (Infectious Diseases, Cardiology, Oncology, Neurology, Ophthalmology, and Metabolic Disorders) - Global Opportunity Analysis and Industry Forecast, 2020-2027”
The Global market size of RNA Interference (RNAi) Drug Delivery Market is $XX million in 2019 and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4134
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key players that operate in the market include Tekmira Pharmaceuticals Corp., Alnylam Pharmaceuticals Inc., Merck & Co. Inc., Isis Pharmaceuticals, Inc., Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Calondo Pharmaceuticals Inc., Marina Biotech Inc., RXi Pharmaceuticals Corp., and Quark Pharmaceuticals Inc.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4134
Key Benefits
• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
• It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
RNAInterference (RNAi) Drug Delivery Market KeySegments:
By Type of Drug Delivery Technology
• Nanoparticle Drug Delivery Technology
• Pulmonary Drug Delivery Technology
• Nucleic Acid Drug Delivery Technology
• Aptamer Drug Delivery Technology
By Application
• Infectious Diseases
• Cardiology
• Oncology
• Neurology
• Ophthalmology
• Metabolic Disorders
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact of COVID-19 on RNA Interference (RNAi) Drug Delivery Market Which Like to Develop Revenue Growth Strategies here
News-ID: 2076464 • Views: …
More Releases from Allied Market Research
Exclusive Report by AMR on Bio Plasticizers Market, Continues to Thrive with USD …
The global bio plasticizers industry generated $1.4 Billion in 2022, and is anticipated to generate $2.4 Billion by 2032, witnessing a CAGR of 5.5% from 2023 to 2032. The global bio plasticizers market is driven by the rising demand from automotive, construction, healthcare, and packaging industries and rise in environmental concerns. However, price competitiveness is anticipated to hinder the growth of the market. Nevertheless, the surge in demand from the…
Aerospace Artificial Intelligence Market Soars to $5.82 Billion by 2028 | Exclus …
Allied Market Research (AMR) recently published a report in which it predicts the global aerospace artificial intelligence market to reach $5,826.1 million in 2028 with a remarkable CAGR of 43.4% from an estimated market size of $373.6 million in 2020. The forecast years for this analysis are from 2021 to 2028. Furthermore, the report presents a comprehensive analysis of the global aerospace artificial intelligence market, including current trends, pricing factors,…
Automotive Logistics Market on Track to Reach $433.6 Billion by 2031, Exclusive …
Allied Market Research recently published a report, titled, "Automotive Logistics Market by Service (Warehousing and Transportation), by Type (Finished Vehicles and Automotive Parts), by Mode of Transport (Land, Air, and Sea), and by Distribution Area (Domestic and International): Global Opportunity Analysis and Industry Forecast, 2021-2031." 𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐭𝐚𝐭𝐞𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐚𝐛 $𝟒𝟑𝟑.𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟐𝟒𝟏.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧…
Exclusive Report by AMR on Refrigerants Market Size and Share, Growing at a CAGR …
The global refrigerants market generated $20.6 billion in 2020, and is projected to reach $42.0 billion by 2030, witnessing a CAGR of 7.4% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape. Refrigerants are substances that are used in refrigeration and air conditioning systems to transfer heat. They are typically volatile liquids or gases that can easily…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
